scispace - formally typeset
B

Bas Kreike

Researcher at Netherlands Cancer Institute

Publications -  36
Citations -  4751

Bas Kreike is an academic researcher from Netherlands Cancer Institute. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 25, co-authored 36 publications receiving 4435 citations.

Papers
More filters
Journal ArticleDOI

Analysis of breast cancer related gene expression using natural splines and the Cox proportional hazard model to identify prognostic associations

TL;DR: Genes encoding important breast cancer-related proteins are studied using a model for survival-type data that is based on natural splines and the Cox proportional hazard model, thereby removing the linearity assumption, and EGFR-expression seems to have a non-linear relation with disease outcome.
Journal ArticleDOI

Uniform FDG-PET guided GRAdient Dose prEscription to reduce late Radiation Toxicity (UPGRADE-RT): study protocol for a randomized clinical trial with dose reduction to the elective neck in head and neck squamous cell carcinoma.

TL;DR: The objective of the UPGRADE-RT trial is to investigate whether de-escalation of elective radiation dose and the introduction of an intermediate dose-level for borderline sized lymph nodes in the treatment of head and neck cancer will result in less radiation sequelae and improved quality of life after treatment without compromising the recurrence rate in the electively treated neck.
Journal ArticleDOI

Are triple-negative tumours and basal-like breast cancer synonymous? Authors' response

TL;DR: The issues raised by Rakha and colleagues in their response to the recent research article are addressed and it is shown that some of these tumours have the gene expression pattern of triple-negative tumours – these are in fact the TNP tumours from this unselected series of tumours.

Classification of ductal carcinoma in situ by gene expression

TL;DR: Using supervised classification, a gene expression classifiers of 35 genes differed between DCIS and invasive breast cancer; a classifier of 43 genes could be identified separating between well- and poorly differentiated DCIS samples.